Extrastriatal dopaminergic dysfunction in tourette syndrome

Tourette syndrome (TS) is a neuropsychiatric disorder presenting with tics and a constellation of nonmotor symptoms that includes attention deficit hyperactivity disorder, obsessive–compulsive disorder, and impulse control disorders. Accumulated evidence from pharmacological trials and postmortem analyses suggests that abnormalities of dopaminergic neurotransmission play a key role in the pathogenesis of TS. A substantial body of evidence has also accrued to implicate regions outside the striatum in the generation of tics.

[1]  C. Nicholson,et al.  Amphetamine Distorts Stimulation-Dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores , 2001, The Journal of Neuroscience.

[2]  D. Ingvar,et al.  COMPULSORY SHOUTING (BENEDEK'S “KLAZOMANIA”) ASSOCIATED WITH OCULOGYRIC SPASMS IN CHRONIC EPIDEMIC ENCEPHALITIS , 1961, Acta psychiatrica Scandinavica.

[3]  A Rothenberger,et al.  Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. , 1997, The American journal of psychiatry.

[4]  K Suzuki,et al.  Reproducibility of [11C]FLB 457 binding in extrastriatal regions , 2001, Nuclear medicine communications.

[5]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[6]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[7]  J. Jankovic,et al.  Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias , 1988, Neurology.

[8]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[9]  S. Pulst,et al.  Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. , 1983, Archives of neurology.

[10]  B. Vogt,et al.  Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.

[11]  D. Gilbert,et al.  Tic reduction with pergolide in a randomized controlled trial in children , 2003, Neurology.

[12]  A. Antonini,et al.  The metabolic anatomy of Tourette's syndrome , 1997, Neurology.

[13]  H. Fibiger,et al.  Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[14]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[15]  F. Tarazi,et al.  Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. , 2001, The Journal of pharmacology and experimental therapeutics.

[16]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[17]  Mark Hallett,et al.  Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results , 1996, Biological Psychiatry.

[18]  A. Braun,et al.  The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness , 1995, Neuropsychopharmacology.

[19]  T. Paus,et al.  Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis , 2000, Experimental Brain Research.

[20]  Peter Herscovitch,et al.  The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. I. Regional Changes in Cerebral Glucose Metabolism Differentiating Patients and Controls , 1993, Neuropsychopharmacology.

[21]  Claus Svarer,et al.  Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. , 2007, The international journal of neuropsychopharmacology.

[22]  Karl J. Friston,et al.  A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.

[23]  A. Anderson,et al.  A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. , 1998, Archives of general psychiatry.

[24]  J. Jankovic,et al.  Long-term effects of tetrabenazine in hyperkinetic movement disorders , 1997, Neurology.

[25]  Jeffrey M Albert,et al.  Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. , 2007, Journal of neurosurgery.

[26]  M. Hamilton,et al.  Rating depressive patients. , 1980, The Journal of clinical psychiatry.

[27]  S Geier,et al.  [Behavioral manifestations induced by electric stimulation of the anterior cingulate gyrus in man]. , 1976, Revue neurologique.

[28]  J. R. Augustine Circuitry and functional aspects of the insular lobe in primates including humans , 1996, Brain Research Reviews.

[29]  Nir Giladi,et al.  Ropinirole in Gilles de la Tourette syndrome , 2004, Neurology.

[30]  E M Wassermann,et al.  Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. , 2001, Advances in neurology.

[31]  L. Cubeddu,et al.  Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. , 1988, The Journal of pharmacology and experimental therapeutics.

[32]  D. Weinberger,et al.  Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. , 1998, Neurology.

[33]  G Bernardi,et al.  Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. , 1993, Brain : a journal of neurology.

[34]  M Hallett,et al.  Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. , 2006, Brain : a journal of neurology.

[35]  D. Durstewitz,et al.  Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons , 2001, The Journal of Neuroscience.

[36]  Yun Zhou,et al.  Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. , 2002, The American journal of psychiatry.

[37]  Z. Kruk,et al.  Differential action of (+)‐amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens , 1994, British journal of pharmacology.

[38]  Eric M. Wassermann,et al.  Transcranial Magnetic Stimulation-Evoked Cortical Inhibition: A Consistent Marker of Attention-Deficit/Hyperactivity Disorder Scores in Tourette Syndrome , 2005, Biological Psychiatry.

[39]  M. Robertson,et al.  Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[40]  M. Trimble,et al.  Dopamine receptor availability in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.

[41]  R. Narendran,et al.  Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride , 2009, Synapse.

[42]  G. Stebbins,et al.  Talipexole and adult Gilles de la tourette's syndrome: Double‐blind, placebo‐controlled clinical trial , 1994, Movement disorders : official journal of the Movement Disorder Society.

[43]  J. Mink,et al.  Response to levodopa challenge in Tourette syndrome , 2000, Movement disorders : official journal of the Movement Disorder Society.

[44]  C. Olson,et al.  Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. , 1992, Cerebral cortex.

[45]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[46]  Karl J. Friston,et al.  Cortical areas and the selection of movement: a study with positron emission tomography , 1991, Experimental Brain Research.

[47]  C. McDougle,et al.  [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. , 1995, The American journal of psychiatry.

[48]  Neal R. Swerdlow,et al.  Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm , 2001, Biological Psychiatry.

[49]  E Stern,et al.  A functional neuroanatomy of tics in Tourette syndrome. , 2000, Archives of general psychiatry.

[50]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[51]  B. Carroll,et al.  Effects of dopamine agonists and antagonists in Tourette's disease. , 1979, Archives of general psychiatry.

[52]  M. Laruelle Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  D. Barch,et al.  Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study , 2004, Biological Psychiatry.

[54]  E. Phelps,et al.  "Willed action": a functional MRI study of the human prefrontal cortex during a sensorimotor task. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Singer,et al.  Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum , 2004, Journal of the Neurological Sciences.

[56]  Matti Laine,et al.  Frontal and Temporal Dopamine Release during Working Memory and Attention Tasks in Healthy Humans: a Positron Emission Tomography Study Using the High-Affinity Dopamine D2 Receptor Ligand [11C]FLB 457 , 2005, The Journal of Neuroscience.

[57]  R. Coppola,et al.  Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding , 1996, Science.

[58]  D. Sulzer,et al.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  L. Descarries,et al.  Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study , 1993, Brain Research.

[60]  G. Sethuraman,et al.  Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide , 1997, Movement disorders : official journal of the Movement Disorder Society.

[61]  J. Talairach,et al.  The cingulate gyrus and human behaviour. , 1973, Electroencephalography and clinical neurophysiology.

[62]  Anthony A Grace,et al.  Opposite Influences of Endogenous Dopamine D1 and D2 Receptor Activation on Activity States and Electrophysiological Properties of Striatal Neurons: Studies CombiningIn Vivo Intracellular Recordings and Reverse Microdialysis , 2002, The Journal of Neuroscience.

[63]  K. Worsley,et al.  A Statistical Method for the Analysis of Positron Emission Tomography Neuroreceptor Ligand Data , 2000, NeuroImage.

[64]  D. Pauls A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. , 1999, American journal of human genetics.

[65]  Christer Halldin,et al.  A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.

[66]  J. Leckman,et al.  Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis , 2007, Journal of the Neurological Sciences.

[67]  H. Singer,et al.  Executive function in fluency and recall measures among children with Tourette syndrome or ADHD , 2001, Journal of the International Neuropsychological Society.

[68]  Andreas Heinz,et al.  Tourette's syndrome , 1998, Neurology.

[69]  Albert Gjedde,et al.  Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET , 2008, Neuropsychopharmacology.

[70]  Peter Herscovitch,et al.  The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates , 2002, Neuropsychopharmacology.

[71]  V. Visser-Vandewalle,et al.  Deep brain stimulation in Tourette's syndrome: Two targets? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[72]  E Wyllie,et al.  Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. , 1994, Electroencephalography and clinical neurophysiology.

[73]  F. Tarazi,et al.  Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: Common targets for typical and atypical antepsychotic drugs , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[74]  B. Christian,et al.  Altered mesolimbocortical and thalamic dopamine in Tourette syndrome , 2006, Neurology.

[75]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[76]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[77]  E. L. Harris,et al.  Executive function in children with Tourette Syndrome and/or Attention Deficit Hyperactivity Disorder , 1995, Journal of the International Neuropsychological Society.

[78]  P. Calabresi,et al.  Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats , 1988, Neuroscience.

[79]  T. Reader,et al.  Dopamine Receptor Agonists Regulate Levels of the Serotonin 5-HT2A Receptor and its mRNA in a Subpopulation of Rat Striatal Neurons , 1996, The Journal of Neuroscience.

[80]  T. Ullrich,et al.  Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism , 2004, Journal of Pharmacology and Experimental Therapeutics.

[81]  G. Sawle,et al.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[82]  Linda J. Schuerholz,et al.  Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder , 1996, Neurology.

[83]  S. Leurgans,et al.  Advantages of a modified scoring method for the rush video‐based tic rating scale , 1999, Movement disorders : official journal of the Movement Disorder Society.

[84]  A. Gjedde,et al.  D2-like dopamine receptor density in Tourette syndrome measured by PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  H. Emrich,et al.  Serotonin transporter binding in Tourette Syndrome , 2005, Neuroscience Letters.

[86]  S. Robertson,et al.  A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters , 2009, Molecular Neurobiology.

[87]  J C Rothwell,et al.  Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. , 2005, Brain : a journal of neurology.

[88]  P. Roland,et al.  Supplementary motor area and other cortical areas in organization of voluntary movements in man. , 1980, Journal of neurophysiology.